Literature DB >> 10508817

Reduced interferon-gamma expression in peripheral blood mononuclear cells of infants with severe respiratory syncytial virus disease.

J H Aberle1, S W Aberle, M N Dworzak, C W Mandl, W Rebhandl, G Vollnhofer, M Kundi, T Popow-Kraupp.   

Abstract

We examined the in vivo cell-mediated immune response in infants with respiratory syncytial virus (RSV) infection in order to gain information about the pathogenesis of severe RSV disease in infancy. Semiquantitative reverse transcription-polymerase chain reaction and three-color flow cytometry were used to determine the levels of messenger RNA (mRNA) for interferon (IFN)-gamma in peripheral blood mononuclear cells, and the distribution of lymphocyte subsets in infants with acute RSV infection. The findings were correlated with the severity of the patients' illness and the production of RSV-specific IgE antibodies (RSV-IgE). Significantly lower IFN-gamma levels and T-lymphocyte counts in the acute phase of illness were observed in infants with severe RSV disease than in those with a milder clinical course of illness. The induction of RSV-IgE was not related to IFN-gamma levels in the acute phase of illness, but rather correlated with IFN-gamma expression during convalescence. The data indicate that reduced IFN-gamma expression may be an important factor in the pathogenesis of severe RSV disease in infancy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10508817     DOI: 10.1164/ajrccm.160.4.9812025

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  50 in total

1.  Selective enhancement of systemic Th1 immunity in immunologically immature rats with an orally administered bacterial extract.

Authors:  L M Bowman; P G Holt
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

Review 2.  Respiratory syncytial virus (RSV) evades the human adaptive immune system by skewing the Th1/Th2 cytokine balance toward increased levels of Th2 cytokines and IgE, markers of allergy--a review.

Authors:  Yechiel Becker
Journal:  Virus Genes       Date:  2006-10       Impact factor: 2.332

3.  Cord blood cytokines and acute lower respiratory illnesses in the first year of life.

Authors:  Ngoc P Ly; Sheryl L Rifas-Shiman; Augusto A Litonjua; Arthur O Tzianabos; Bianca Schaub; Begoña Ruiz-Pérez; Kelan G Tantisira; Patricia W Finn; Matthew W Gillman; Scott T Weiss; Diane R Gold
Journal:  Pediatrics       Date:  2006-12-04       Impact factor: 7.124

Review 4.  Neonatal innate immunity to infectious agents.

Authors:  László Maródi
Journal:  Infect Immun       Date:  2006-04       Impact factor: 3.441

5.  Prospective multicenter study of viral etiology and hospital length of stay in children with severe bronchiolitis.

Authors:  Jonathan M Mansbach; Pedro A Piedra; Stephen J Teach; Ashley F Sullivan; Tate Forgey; Sunday Clark; Janice A Espinola; Carlos A Camargo
Journal:  Arch Pediatr Adolesc Med       Date:  2012-08

Review 6.  Epidemiology of Infections and Development of Asthma.

Authors:  Jenny Resiliac; Mitchell H Grayson
Journal:  Immunol Allergy Clin North Am       Date:  2019-04-30       Impact factor: 3.479

Review 7.  The immune response to respiratory syncytial virus infection: friend or foe?

Authors:  Robert C Welliver
Journal:  Clin Rev Allergy Immunol       Date:  2008-04       Impact factor: 8.667

8.  Multicenter study of viral etiology and relapse in hospitalized children with bronchiolitis.

Authors:  Kohei Hasegawa; Jonathan M Mansbach; Stephen J Teach; Erin S Fisher; Daniel Hershey; Joyce Y Koh; Sunday Clark; Pedro A Piedra; Ashley F Sullivan; Carlos A Camargo
Journal:  Pediatr Infect Dis J       Date:  2014-08       Impact factor: 2.129

9.  Decreased interferon-gamma response in respiratory syncytial virus compared to other respiratory viral infections in infants.

Authors:  J H Aberle; S W Aberle; W Rebhandl; E Pracher; M Kundi; T Popow-Kraupp
Journal:  Clin Exp Immunol       Date:  2004-07       Impact factor: 4.330

Review 10.  Role of viruses in the development of atopic disease in pediatric patients.

Authors:  Dorothy S Cheung; Mitchell H Grayson
Journal:  Curr Allergy Asthma Rep       Date:  2012-12       Impact factor: 4.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.